USD10
Akcje ABBV
Informacje o AbbVieAbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
USD10
Akcje ABBV
Informacje o AbbVieAbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Statystyki
OKNO HANDLOWE
Zamknięta
OTWARCIE O
27 mar at 13:30 GMT+0
KAPITALIZACJA RYNKU
368,79 mld USD
CENA OTWARCIA
211,42 USD
MINIMUM (1Y)
164,39 USD
MAKSIMUM (1Y)
244,81 USD
MINIMUM (24H)
209,12 USD
MAKSIMUM (24H)
213,49 USD
WOLUMEN (24H)
5,65 mln USD
23,56%
Historia cen
Time | Price | Change |
|---|---|---|
Dzisiaj | 211,42 USD | |
1 dzień | 210,96 USD | |
1 tydzień | 206,56 USD |